Dario C. Altieri, M.D., president and chief executive officer of The Wistar Institute will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities o…
PHILADELPHIA—(Sep. 18, 2023)—Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has pu…
PHILADELPHIA—(Sept. 7, 2023)—The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the recruitment of Avi Srivastav…
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the recruitment of Jesper Pallesen, MBA, Ph.D., as assistant …
PHILADELPHIA—(August 22, 2023)—Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the…
PHILADELPHIA (August 14, 2023) – Partners in Greater Philadelphia’s life sciences ecosystem are expanding their commitment to connecting a wider range of Philadelphians, including residents from di…
PHILADELPHIA—(August 9, 2023)— The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the appointment of Alexander P…
Philadelphia – (August 8, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joy Taylor to its Boar…
PHILADELPHIA — (JULY 26, 2023) — It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its connection to lymphomas. N…
PHILADELPHIA — (July 19, 2023) — Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, researchers from The…
